Parotid Tumors Market Information: By Type (Pleomorphic Adenoma), Treatment (Removal Of Lymph Node, Radiation Therapy, Chemotherapy), Diagnosis (Ct Scan, Ultrasound, Sialography) And End Users (Hospitals, Specialty Centers) - Forecast Till 2027
Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6. Global Parotid Tumors Market, by Type
6.1 Introduction
6.2 Pleomorphic Adenoma
6.2.1 Market Estimates & Forecast, 2020-2027
6.3 Warthin's Tumor
6.3.1 Market Estimates & Forecast, 2020-2027
6.4 Cancerous/Malignant Tumor
6.4.1 Market Estimates & Forecast, 2020-2027
7. Global Parotid Tumors Market, by Diagnosis
7.1 Introduction
7.2 X-Ray
7.2.1 Market Estimates & Forecast, 2020-2027
7.3 CT Scan
7.3.1 Market Estimates & Forecast, 2020-2027
7.4 MRI
7.4.1 Market Estimates & Forecast, 2020-2027
7.5 Ultrasound
7.5.1 Market Estimates & Forecast, 2020-2027
7.6 FNAC (Fine Needle Aspiration Cytology)
7.6.1 Market Estimates & Forecast, 2020-2027
7.7 Sialography
7.7.1 Market Estimates & Forecast, 2020-2027
7.8 Others
7.8.1 Market Estimates & Forecast, 2020-2027
8. Global Parotid Tumors Market, by Treatment
8.1 Introduction
8.2 Parotidectomy
8.2.1 Market Estimates & Forecast, 2020-2027
8.3 Removal of Lymph Node
8.3.1 Market Estimates & Forecast, 2020-2027
8.4 Reconstructive Surgery
8.4.1 Market Estimates & Forecast, 2020-2027
8.5 Radiation Therapy
8.5.1 Market Estimates & Forecast, 2020-2027
8.6.1 Market Estimates & Forecast, 2020-2027
9. Global Parotid Tumors Market, by End User
9.1 Introduction
9.2 Hospitals
9.2.1 Market Estimates & Forecast, 2020-2027
9.3 Specialty centers
9.3.1 Market Estimates & Forecast, 2020-2027
9.4 Research centers
9.4.1 Market Estimates & Forecast, 2020-2027
10 Global Parotid Tumors Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 U.K.
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
12 Company Profiles
12.1 Eli lilly & Co
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 SWOT Analysis
12.2 Bayer AG
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Merck & Co. Inc.
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Pfizer Inc.
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Bristol-Myers Squibb
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.6 Janssen Global Services, LLC
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 Hoffmann-La Roche Ltd
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Others
13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Pharmaceutical Industry
14 Appendix
LIST OF TABLES
Table 1 Parotid Tumors Industry Synopsis, 2020-2027
Table 2 Global Parotid Tumors Market Estimates and Forecast, 2020-2027, (USD Million)
Table 3 Global Parotid Tumors Market by Region, 2020-2027, (USD Million)
Table 5 Global Parotid Tumors Market by Treatment, 2020-2027, (USD Million)
Table 6 Global Parotid Tumors Market by Diagnosis, 2020-2027, (USD Million)
Table 7 Global Parotid Tumors Market by End Users, 2020-2027, (USD Million)
Table 8 North America Parotid Tumors Market by Treatment, 2020-2027, (USD Million)
Table 9 North America Parotid Tumors Market by Daignosis, 2020-2027, (USD Million)
Table 10 North America Parotid Tumors Market by End Users, 2020-2027, (USD Million)
Table 11 US Parotid Tumors Market by Treatment, 2020-2027, (USD Million)
Table 12 US Parotid Tumors Market by Daignosis, 2020-2027, (USD Million)
Table 13 US Parotid Tumors Market by End Users, 2020-2027, (USD Million)
Table 14 Canada Parotid Tumors Market by Treatment, 2020-2027, (USD Million)
Table 15 Canada Parotid Tumors Market by Daignosis, 2020-2027, (USD Million)
Table 16 Canada Parotid Tumors Market by End Users, 2020-2027, (USD Million)
Table 17 South America Parotid Tumors Market by Treatment, 2020-2027, (USD Million)
Table 18 South America Parotid Tumors Market by Diagnosis, 2020-2027, (USD Million)
Table 19 South America Parotid Tumors Market by End Users, 2020-2027, (USD Million)
Table 20 Europe Parotid Tumors Market by Treatment, 2020-2027, (USD Million)
Table 21 Europe Parotid Tumors Market by Diagnosis, 2020-2027, (USD Million)
Table 22 Europe Parotid Tumors Market by End Users, 2020-2027, (USD Million)
Table 23 Western Europe Parotid Tumors Market by Treatment, 2020-2027, (USD Million)
Table 24 Western Europe Parotid Tumors Market by diagnosis, 2020-2027, (USD Million)
Table 25 Western Europe Parotid Tumors Market by End Users, 2020-2027, (USD Million)
Table 26 Eastern Europe Parotid Tumors Market by Treatment, 2020-2027, (USD Million)
Table 27 Eastern Europe Parotid Tumors Market by diagnosis, 2020-2027, (USD Million)
Table 28 Eastern Europe Parotid Tumors Market by End Users, 2020-2027, (USD Million)
Table 29 Asia Pacific Parotid Tumors Market by Treatment, 2020-2027, (USD Million)
Table 30 Asia Pacific Parotid Tumors Market by diagnosis, 2020-2027, (USD Million)
Table 31 Asia Pacific Parotid Tumors Market by End Users, 2020-2027, (USD Million)
Table 32 Middle East & Africa Parotid Tumors Market by Treatment, 2020-2027, (USD Million)
Table 33 Middle East & Africa Parotid Tumors Market by diagnoses, 2020-2027, (USD Million)
Table 34 Middle East & Africa Parotid Tumors Market by End Users, 2020-2027, (USD Million)
 
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Parotid Tumors Market
Figure 3 Segmentation Market Dynamics for Parotid Tumors Market
Figure 4 Global Parotid Tumors Market Share, by Treatment 2020
Figure 5 Global Parotid Tumors Market Share, by Diagnosis 2020
Figure 6 Global Parotid Tumors Market Share, by End Users, 2020
Figure 7 Global Parotid Tumors Market Share, by Region, 2020
Figure 8 North America Parotid Tumors Market Share, by Country, 2020
Figure 9 Europe Parotid Tumors Market Share, by Country, 2020
Figure 10 Asia Pacific Parotid Tumors Market Share, by Country, 2020
Figure 11 Middle East & Africa Parotid Tumors Market Share, by Country, 2020
Figure 12 Global Parotid Tumors Market: Company Share Analysis, 2020 (%)
Figure 13 Bayer AG: Key Financials
Figure 14 Bayer AG: Segmental Revenue
Figure 16 Bayer AG: Geographical Revenue
Figure 17 Pfizer Inc.: Key Financials
Figure 18 Pfizer Inc.: Segmental Revenue
Figure 19 Pfizer Inc.: Geographical Revenue
Figure 20 Hoffmann-La Roche Ltd: Key Financials
Figure 21 Hoffmann-La Roche Ltd: Segmental Revenue
Figure 22 Hoffmann-La Roche Ltd: Geographical Revenue
Figure 23 Novartis AG: Key Financials
Figure 24 Novartis AG: Segmental Revenue
Figure 25 Novartis AG: Geographical Revenue
Figure 26 AstraZeneca: Key Financials
Figure 27 AstraZeneca: Segmental Revenue
Figure 28 AstraZeneca: Geographical Revenue
Figure 29 Amgen: Key Financials
Figure 30 Amgen: Segmental Revenue
Figure 31 Amgen: Geographical Revenue
Figure 32 Johnson & Johnson: Key Financials
Figure 33 Johnson & Johnson: Segmental Revenue
Figure 34 Johnson & Johnson: Geographical Revenue
Speak to Analyst
Request a Free Sample
Parotid Tumors Market Scenario
Parotid Tumors are abnormal growth within the salivary gland. The parotid glands are prone to various conditions like fibrous reaction, parotitis, salivary stones, injury, cancers, and parotid tumors. The parotid tumor can be cancerous or non-cancerous.
Parotid Tumors can be caused by various reasons such as certain abdominal surgery, liver cirrhosis, dehydration, salivary gland infections, metastasis of cancer, and salivary duct stones.
The parotid tumors market is majorly driven by growing prevalence of cancer, growing liver cirrhosis, and rising consumption of alcohol. Additionally, factors such as government initiatives and support, rising demand for advanced technologies and growing market players offering newer products are likely to drive the market.
According to Cancer Research U.K, around 14.1 million cases of cancer were diagnosed in 2014. Additionally, according to national cancer institute in 2014, around 14.5 million cases of cancer went undiagnosed. Such statistics has propelled the overall number of cancer cases and thereby are likely to drive the growth of parotid tumors market.
Factors that are likely to hamper the growth of the market are the complications that will arise after the needed treatment.
Parotid Tumors market is expected to grow at a CAGR of 7.1% during the forecasted period.
Figure: Global Parotid Tumors Market, by Region, 2017 (%)
Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, market research future analysis, annual report, white paper, company presentation
Intended Audience
- Pharmaceutical Manufacturers and Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Research Methodology:
Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, market research future analysis, annual report, white paper, company presentation
Segments
The parotid tumors market is segmented on the basis of type, treatment, diagnosis and end users.
By the type Pleomorphic Adenoma, Warthin's Tumor and Cancerous/Malignant Tumor.
On the basis of treatment, the parotid tumors market is segmented into Parotidectomy, Removal of Lymph Node, Reconstructive Surgery, Radiation Therapy, and Chemotherapy.
By diagnosis, the parotid tumors market is segmented into X-ray, CT scan, MRI, Ultrasound, FNAC (Fine Needle Aspiration Cytology), Sialography, and others.
On the basis of the end users, the parotid tumors market is segmented into hospitals, Specialty centers, and Research centers.
Regional Analysis
North America Parotid Tumors market is a growing market in the Americas region. On a regional basis, Americas region is segmented into North America and South America. North America is segmented into US and Canada. Increasing number of cancer and rising consumption of alcohol among the masses is likely to drive the growth of North America Parotid Tumors market. Additionally, rising healthcare expenditure is likely to drive the growth of the market. For instance, according to National Institute on alcohol abuse and alcoholism, in 2015, around 26.9% individuals aged 18 and above are engaged in drinking.Similarly, according to Agency for Healthcare Research and Quality (AHRQ), around USD 80.2 billion was spent in cancer treatment.
Europe is the second largest market and holds a noticeable share in the Parotid Tumors market. The European market is expected to grow a healthy growth during the forecast period owing to the availability of newer and advanced treatment facilities, and rising skilled medical professionals along with growing need for better healthcare infrastructure. Furthermore, extensive research and development activities for the treatment of disease and increasing government support and initiative boost the parotid tumors market growth.
Asia Pacific is expected to be the fastest growing market. Increasing prevalence of chronic diseases is the major driver for the market growth. India is the fastest growing region owing to an increasing population. Rising awareness about the health and availability of new treatment methods drive the market in this region. Rising healthcare expenditure and overall growth of healthcare diagnostic and treatment industry also drive the parotid tumors market.
The Middle East & Africa is expected to show the least growth in the parotid tumors market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, United Arab Emirates is the largest market share owing to the development of healthcare industry and rising availability of specialty care centers.
Key Players
Some of the players in the Parotid Tumors market are Eli Lilly & Co, Bayer AG, Merck & Co. Inc., Pfizer Inc., Bristol-Myers Squibb, Janssen Global Services, LLC, Hoffmann-La Roche Ltd, and Novartis AG.
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant Value |
| CAGR | 7.1% (2017-2023 |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Treatment, Diagnosis, End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Eli Lilly & Co, Bayer AG, Merck & Co. Inc., Pfizer Inc., Bristol-Myers Squibb, Janssen Global Services, LLC, Hoffmann-La Roche Ltd, and Novartis AG. |
| Key Market Opportunities | Growing market players offering newer products |
| Key Market Drivers |
|
